The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.1M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 698K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

10 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
An insight on synthetic and medicinal aspects of pyrazolo[1,5-a]pyrimidine scaffold.EBI
University of Kwazulu-Natal
A perspective on targeting non-structural proteins to combat neglected tropical diseases: Dengue, West Nile and Chikungunya viruses.EBI
University of Kwazulu-Natal
A brief overview on recent advances in spiro[chromane-2,4'-piperidine]-4(3H)-one-functionalized compounds in medicinal chemistry research.EBI
University of Kwazulu-Natal
Current anti-diabetic agents and their molecular targets: A review.EBI
University of Kwazulu-Natal
Therapeutic significance of β-glucuronidase activity and its inhibitors: A review.EBI
University of Kwazulu-Natal
Synthesis and molecular modelling studies of novel carbapeptide analogs for inhibition of HIV-1 protease.EBI
University of Kwazulu-Natal
Synthesis and structural studies of pentacycloundecane-based HIV-1 PR inhibitors: a hybrid 2D NMR and docking/QM/MM/MD approach.EBI
University of Kwazulu-Natal
Pentacycloundecane-based inhibitors of wild-type C-South African HIV-protease.EBI
University of Kwazulu-Natal
An appraisal on synthetic and pharmaceutical perspectives of pyrazolo[4,3-d]pyrimidine scaffold.EBI
University of Kwazulu-Natal